Alessio Cantore

2.6k total citations
30 papers, 1.7k citations indexed

About

Alessio Cantore is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Alessio Cantore has authored 30 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Genetics, 21 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Alessio Cantore's work include Virus-based gene therapy research (22 papers), CRISPR and Genetic Engineering (10 papers) and CAR-T cell therapy research (9 papers). Alessio Cantore is often cited by papers focused on Virus-based gene therapy research (22 papers), CRISPR and Genetic Engineering (10 papers) and CAR-T cell therapy research (9 papers). Alessio Cantore collaborates with scholars based in Italy, United States and Germany. Alessio Cantore's co-authors include Luigi Naldini, Brian D. Brown, Andrea Annoni, Alessia Baccarini, Lucia Sergi Sergi, Anna Zingale, Giovanna Lazzari, Bernhard Gentner, Silvia Colleoni and Mario Amendola and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Alessio Cantore

29 papers receiving 1.6k citations

Peers

Alessio Cantore

GENET

ONCOL

IMMUN

Andrea Annoni Italy

Fabrizio Benedicenti Italy

Olga Kustikova Germany

Francesca Ficara Italy

Helena Costa Verdera France

Jennifer E. Adair United States

Stephanie Laufs Germany

Samuel L. Murphy United States

Andrea Calabria Italy

Nanette Mittereder United States

Andrea Annoni Italy

Alessio Cantore

993 ×0.8

963 ×1.1

GENET

414 ×1.1

ONCOL

106 ×0.4

334 ×2.1

IMMUN

Citations per year, relative to Alessio Cantore Alessio Cantore (= 1×) peers Andrea Annoni

Countries citing papers authored by Alessio Cantore

Since Specialization

Citations

This map shows the geographic impact of Alessio Cantore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessio Cantore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessio Cantore more than expected).

Fields of papers citing papers by Alessio Cantore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessio Cantore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessio Cantore. The network helps show where Alessio Cantore may publish in the future.

Co-authorship network of co-authors of Alessio Cantore

This figure shows the co-authorship network connecting the top 25 collaborators of Alessio Cantore. A scholar is included among the top collaborators of Alessio Cantore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessio Cantore. Alessio Cantore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Volpin, Monica, Anna Fabiano, Mauro Biffi, et al.. (2025). Enhancing the potency of in vivo lentiviral vector mediated gene therapy to hepatocytes. Nature Communications. 16(1). 4802–4802. 1 indexed citations

Thornburg, Courtney D., et al.. (2025). Clinical perspective: Advancing hemophilia treatment through gene therapy approaches. Molecular Therapy. 33(6). 2350–2362.

Barbon, Elena, et al.. (2024). In vivo liver targeted genome editing as therapeutic approach: progresses and challenges. SHILAP Revista de lepidopterología. 6. 1458037–1458037. 3 indexed citations

Cattaneo, Stefano, Laila Asth, Maria Regoni, et al.. (2024). Gene therapy for epilepsy targeting neuropeptide Y and its Y2 receptor to dentate gyrus granule cells. EMBO Reports. 25(10). 4387–4409. 6 indexed citations

Merlin, Simone, Ester Borroni, Mauro Biffi, et al.. (2024). GP64-pseudotyped lentiviral vectors target liver endothelial cells and correct hemophilia A mice. EMBO Molecular Medicine. 16(6). 1427–1450. 7 indexed citations

Liu, Tongyao, Mauro Biffi, Fabio Russo, et al.. (2022). Liver-directed lentiviral gene therapy corrects hemophilia A mice and achieves normal-range factor VIII activity in non-human primates. Nature Communications. 13(1). 2454–2454. 26 indexed citations

Agarwal, Shiwani, et al.. (2022). In vivo generation of CAR T cells in the presence of human myeloid cells. Molecular Therapy — Methods & Clinical Development. 26. 144–156. 19 indexed citations

Tiyaboonchai, Amita, Sean Nygaard, Shelley R. Winn, et al.. (2021). Therapeutic liver repopulation by transient acetaminophen selection of gene-modified hepatocytes. Science Translational Medicine. 13(597). 17 indexed citations

Cantore, Alessio & Luigi Naldini. (2020). WFH State‐of‐the‐art paper 2020: In vivo lentiviral vector gene therapy for haemophilia. Haemophilia. 27(S3). 122–125. 25 indexed citations

10.

Soldi, Monica, Lucia Sergi Sergi, Giulia Unali, et al.. (2020). Laboratory-Scale Lentiviral Vector Production and Purification for Enhanced Ex Vivo and In Vivo Genetic Engineering. Molecular Therapy — Methods & Clinical Development. 19. 411–425. 25 indexed citations

11.

Annoni, Andrea, Federica Moalli, Tongyao Liu, et al.. (2019). Phagocytosis-shielded lentiviral vectors improve liver gene therapy in nonhuman primates. Science Translational Medicine. 11(493). 91 indexed citations

12.

Ciccocioppo, Rachele, Alessio Cantore, Deborah Chaimov, & Giuseppe Orlando. (2019). Regenerative medicine: the red planet for clinicians. Internal and Emergency Medicine. 14(6). 911–921. 23 indexed citations

13.

Annoni, Andrea, Silvia Gregori, Luigi Naldini, & Alessio Cantore. (2018). Modulation of immune responses in lentiviral vector-mediated gene transfer. Cellular Immunology. 342. 103802–103802. 63 indexed citations

14.

Cantore, Alessio, Andrea Annoni, Tongyao Liu, et al.. (2017). Liver-Directed Gene Therapy for Hemophilia B with Immune Stealth Lentiviral Vectors. Blood. 130. 605–605. 4 indexed citations

15.

Annoni, Andrea, Mauro Biffi, Fabio Russo, et al.. (2017). Genome editing for scalable production of alloantigen‐free lentiviral vectors for in vivo gene therapy. EMBO Molecular Medicine. 9(11). 1558–1573. 44 indexed citations

16.

Akbarpour, Mahzad, Kevin Goudy, Alessio Cantore, et al.. (2015). Insulin B chain 9–23 gene transfer to hepatocytes protects from type 1 diabetes by inducing Ag-specific FoxP3 ⁺ T _regs. Science Translational Medicine. 7(289). 289ra81–289ra81. 54 indexed citations

17.

Mátrai, Janka, Alessio Cantore, Cynthia C. Bartholomae, et al.. (2010). Integration-defective lentiviral vectors for hemophilia: a safer platform for immune tolerance inducation and reduced genotoxicity. Molecular Therapy. 1 indexed citations

18.

Mátrai, Janka, Marinee Chuah, Alessio Cantore, et al.. (2009). Sustained therapeutic factor IX expression in liver using integration-deficient lentiviral vectors.. Human Gene Therapy. 20. 1409–1409. 1 indexed citations

19.

Brown, Brian D., Alessio Cantore, Andrea Annoni, et al.. (2007). A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice. Blood. 110(13). 4144–4152. 194 indexed citations

20.

Brown, Brian D., Bernhard Gentner, Alessio Cantore, et al.. (2007). Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nature Biotechnology. 25(12). 1457–1467. 449 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact